Long-term Glycemic Outcomes for 546 T2DM Patients in a TCM Hospital, 2017-2021

546 patients with type 2 diabetes mellitus were followed for up to 36 months in a real-world study at Guangdong Provincial Hospital of Traditional Chinese Medicine. HbA1c levels decreased significantly, with target attainment rising from 30% at baseline to 49% at 12 months. The dataset, authored by Xiuming Li and last updated in 2026, contains longitudinal clinical and behavioral outcomes from a chronic disease management platform.

Use Cases

• Modeling longitudinal HbA1c trajectories based on baseline glycemic control levels mentioned in the description
• Analyzing factors associated with sustained glycemic target attainment (<7.0%) over a 3-year follow-up
• Comparing clinical outcome trends (HbA1c, FBG, PBG, BMI) with self-reported lifestyle behavior changes
• Evaluating the differential effectiveness of platform-based management for patient subgroups (e.g., baseline HbA1c >9.0%)

Strengths

• Real-world longitudinal data spanning up to 36 months of follow-up
• Includes 546 patient records from a defined clinical setting
• Contains multiple outcome measures: HbA1c, FBG, PBG, BMI, and self-reported behaviors
• Clear primary results: HbA1c target attainment increased from 30% to 49% at 12 months

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data is contained in a DOCX file (24.0 KB), suggesting a summary table rather than a raw patient-level dataset

Provenance

Source

Guangdong Provincial Hospital of Traditional Chinese Medicine

Collection Method

Real-world retrospective observational study of patients enrolled in a hospital-based chronic disease management platform

Time Range

Patients enrolled between January 2017 and December 2018, followed for up to 36 months

Freshness

Last updated 2026-04-23 04:20:24; freshness should be verified

Geography

China (Guangdong Province)